Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Theravance Biopharma, Inc.

NASDAQ: TBPH · Life Sciences · 2 alerts · CIK 1583107

Shares outstanding
51.92MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Theravance Biopharma, Inc. filings on SEC EDGAR ↗

4:18 PM ET 8-K
M&A Deal

Theravance Biopharma M&A Deal with Zymeworks Inc.

Theravance Biopharma, Inc. completed its merger with Zymeworks Inc., becoming a wholly owned subsidiary of Zymeworks. Shareholders received $17.00 in cash per share plus one contingent value right (CVR) per share. The transaction was finalized on September 23, 2026, following the original merger agreement signed in June 2026.

Counterparty
Zymeworks Inc.
5:17 PM ET 8-K
M&A Deal

Theravance Biopharma M&A Deal with Zymeworks Inc.

Theravance Biopharma shareholders approved the company's acquisition by Zymeworks Inc. at an extraordinary general meeting. Under the terms of the merger agreement, Theravance will become a wholly owned subsidiary of Zymeworks. The approval included the merger plan, the contingent value rights agreement, and related corporate restructuring.

Counterparty
Zymeworks Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.